General Information
Drug ID
DR00404
Drug Name
Valganciclovir
Synonyms
5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7-dihydro-3H-imidazo[4,5-d]pyrimidin-7-one; Cymeval; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester; L-Valine, ester with ganciclovir; RO1079070/194; RS 79070; Valcyte (TN); Valganciclovir (INN); Valganciclovir (Oral); Valganciclovir [INN:BAN]; [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate
Drug Type
Small molecular drug
Indication Cytomegalovirus infections [ICD11: 1D82] Approved [1]
Therapeutic Class
Antiviral Agents
Structure
3D MOL 2D MOL
Formula
C14H22N6O5
Canonical SMILES
CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N
InChI
InChI=1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8?,9-/m0/s1
InChIKey
WPVFJKSGQUFQAP-GKAPJAKFSA-N
CAS Number
CAS 175865-60-8
Pharmaceutical Properties Molecular Weight 354.36 Topological Polar Surface Area 167
Heavy Atom Count 25 Rotatable Bond Count 9
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 8
XLogP
-1.5
PubChem CID
135413535
PubChem SID
104330216 , 117576840 , 123099361 , 126681567 , 129616655 , 134337936 , 135022474 , 135611114 , 137260967 , 141634799 , 142044094 , 14852135 , 14852136 , 152035502 , 152105972 , 15916891 , 160647806 , 160964847 , 162205159 , 16292870 , 163621140 , 164830911 , 16867892 , 172086164 , 178101427 , 184546497 , 184823771 , 223661894 , 226416180 , 237715327 , 251916051 , 251917399 , 43121054 , 46505524 , 47205808 , 50064546 , 50113281 , 50647485 , 57315041 , 615108 , 7980872 , 91616537 , 92251598
ChEBI ID
CHEBI:63635
TTD Drug ID
D06GWF
DT(s) Transporting This Drug ASCT2 Transporter Info Alanine/serine/cysteine/threonine transporter 2 Substrate [2]
PEPT1 Transporter Info Peptide transporter 1 Substrate [3]
References
1 Valganciclovir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB(0,+). Pharm Res. 2004 Jul;21(7):1303-10.
3 Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci. 2000 Jun;89(6):781-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.